Skip to main content
TipRanks
Go Ultimate75% OFF

National Healthcare (NHC) AI Stock Analysis

146 Followers
NHC

National Healthcare

(NYSE MKT:NHC)

Select Model
Rating:68Neutral
Price Target:$226.00â–²(9.08% Upside)
Action:downgraded
Date:11/06/26

NHC’s strong financial performance is the primary positive factor, supported by improving cash generation and substantial revenue growth. The score is restrained by weaker technical momentum, relatively elevated valuation, declining margins, and increased debt.

Positive Factors
Sustained Revenue GrowthNHC has expanded revenue across several years, indicating continued demand for its post-acute, senior living, homecare, and hospice services. This scale growth can support broader operating leverage, strengthen market presence, and provide a durable base for future earnings generation.
Negative Factors
Higher Financial LeverageThe sharp increase in leverage reduces NHC’s balance-sheet flexibility and makes results more sensitive to any operating slowdown. Higher debt can also constrain future capital allocation and increase the importance of maintaining strong cash generation across the next several quarters.

National Healthcare (NHC) vs. SPDR S&P 500 ETF (SPY)

-20%0%20%40%60%80%100%NHC+65.11%SPY+12.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$3.25B
Dividend Yield
1.26%
Average Volume (3M)
121.57K
Price to Earnings (P/E)
27.8
Beta (1Y)
0.26
Revenue Growth
5.71%
EPS Growth
12.44%
Country
US
Employees
15,278
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

National Healthcare Business Overview & Revenue Model

Company Description

National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing...

How the Company Makes Money

NHC generates revenue primarily from (1) providing patient care and resident services across its senior care facilities and (2) earning fees for managing healthcare and senior living operations for third parties. 1) Patient care and resident service...

National Healthcare Financial Statement Overview

Summary

Strong revenue growth, positive profitability, improving operating and free cash flow, and a healthy equity base support the score. Declining margins and a substantial increase in debt are the main weaknesses.

Income Statement

78Positive

Balance Sheet

73Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.58B1.52B1.30B1.14B1.07B1.01B
Gross Profit752.86M596.70M487.01M429.20M388.11M344.88M
EBITDA207.86M213.72M182.53M131.10M68.28M191.56M
Net Income114.66M120.02M101.93M66.80M22.45M138.59M
Balance Sheet
Total Assets2.07B1.53B1.52B1.31B1.28B1.40B
Cash, Cash Equivalents and Short-Term Investments221.32M309.18M216.19M223.62M182.59M256.02M
Total Debt518.37M87.07M214.77M93.39M125.94M166.66M
Total Liabilities936.98M451.90M541.27M400.32M397.94M494.94M
Stockholders Equity1.12B1.07B980.16M908.75M874.28M903.00M
Cash Flow
Free Cash Flow175.71M148.63M79.70M83.31M-21.46M23.00M
Operating Cash Flow221.76M185.08M107.30M111.22M8.74M62.39M
Investing Cash Flow-671.38M-33.86M-236.69M-17.57M-5.98M-65.89M
Financing Cash Flow384.41M-135.96M100.34M-42.55M-47.64M-35.26M

National Healthcare Technical Analysis

Technical Analysis SentimentNegative
Last Price207.19

Price Trends

50DMA222.58Negative
100DMA221.32Negative
200DMA196.88Positive

Market Momentum

MACD-5.12Positive
RSI40.19Neutral
STOCH51.74Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHC, the sentiment is Negative. The current price of 207.19 is below the 20-day moving average (MA) of 215.98, below the 50-day MA of 222.58, and above the 200-day MA of 196.88, indicating a neutral trend. The MACD of -5.12 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 51.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NHC.

National Healthcare Risk Analysis

National Healthcare disclosed 32 risk factors in its most recent earnings report. National Healthcare reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.The status of our lease with National Health Investors, Inc. creates uncertainties and risks to our future operations.Q4, 2025
2.Federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient census and profitability.Q4, 2024
3.We face uncertainty related to the COVID-19 public health emergency's ("PHE") expiration and wind-down, which could have a material adverse affect on our business, financial condition, results of operations and cash flows.Q4, 2023

National Healthcare Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

NHC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ADUSADUS83Outperform$2.32B20.719.81%―11.53%27.72%
ENSGENSG75Outperform$10.98B27.1316.63%0.14%17.49%19.82%
PACSPACS71Outperform$7.78B27.9525.77%―11.02%62.56%
NHCNHC68Neutral$3.25B27.8310.41%1.26%5.71%12.44%
PNTGPNTG61Neutral$1.30B35.4110.15%―38.67%33.07%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
BKDBKD47Neutral$2.14B-56.0788.80%―-8.42%87.98%

* Healthcare Sector Average

Performance Comparison

0%50%100%150%NHCADUSBKDENSGPNTGPACSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
NHC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NHCNational Healthcare207.1982.9066.69%
ADUSAddus HomeCare Corporation124.6115.6114.32%
BKDBrookdale Senior Living Inc.8.96-1.53-14.59%
ENSGThe Ensign188.239.785.48%
PNTGPennant Group Inc37.0310.8741.55%
PACSPACS Group Inc49.0032.17191.15%

National Healthcare Corporate Events

Business Operations and StrategyDividends

National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability

Positive
Aug 11, 2026

On August 6, 2026, National HealthCare Corporation announced it will pay a quarterly cash dividend of $0.67 per common share, reinforcing its ongoing practice of returning capital to shareholders. The dividend will be paid on October 30, 2026, to sha...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026